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Abstract
Background: Chronic infection with Theiler’s murine encephalomyelitis virus (TMEV) in susceptible SJL/J mice
induces an immune-mediated demyelinating disease and has extensively been used as a relevant infectious model
for multiple sclerosis (MS). Infection of the host with many other viruses also leads to acute or chronic inflammatory
diseases in the central nervous system (CNS). Levels of viral load in the host often play a critical role in the pathogenesis
of virus-induced diseases. Thus, the inhibition of viral replication in the host against a broad spectrum of similar viruses is
critically important for preventing the viral pathogenicity.
Methods: P2/P3-expressing transgenic (B6 X SJL)F1 founders were generated and bred onto the C57BL/6 and
SJL/J backgrounds. Differences in the development of demyelinating disease were compared. Viral persistence,
cytokine production, and immune responses in the CNS of infected control and P2/P3-Tg mice were analyzed
after infection using quantitative PCR, ELISA, and flow cytometry. Various cell types from the control and
P2/P3-Tg mice, as well as cells transfected in vitro with the P2 and/or P3 regions, were also analyzed for viral
replication and innate cytokine production.
Results: P2/P3-transgenic (P2/P3-Tg) mice carrying the viral non-structural protein genes displayed significantly
reduced virus-specific T cell responses in the CNS against both the structural and non-structural proteins. Consequently,
viral loads in the CNS were greater in the Tg mice during the chronic infection. However, P2/P3-Tg SJL mice exhibited
reduced disease incidence and less severe clinical symptoms than did their non-transgenic littermates. Interestingly,
P2/P3-Tg mice showed low viral loads in the CNS at a very early period after infection (1–3 days) with TMEV and
related EMCV but not unrelated VSV. Cells from P2/P3-Tg mice and cells transfected with the P2 and/or P3 regions in
vitro yielded also lower viral replication but higher IFN-α/β production.
Conclusions: This study demonstrates that the expression of viral non-structural genes in mice inhibits initial viral
replication and suppresses sustaining pathogenic anti-viral immune responses to broad viral determinants. It
appears that the elevation of innate immune cytokines produced in the cells expressing the non-structural viral
genes upon viral infection is responsible for the inhibitions. The inhibition is partially virus-specific as it is more
efficient for a related virus compared to an unrelated virus, suggesting a role for the similarity in the viral
genome structures. Therefore, the expression of viral non-structural genes may serve as a useful new method to
prevent a broadly virus-specific pathogenesis in the hosts.
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Background
Theiler’s murine encephalomyelitis virus (TMEV)-in-
duced demyelinating disease has been extensively stud-
ied as a relevant animal model for human multiple
sclerosis (MS). Intracerebrally infected susceptible SJL/J
mice develop neuropathological symptoms that exhibit
many immunological and pathological similarities to MS
and thus serve as an infectious model for this immune-
mediated disease [1, 2]. Immune responses have been
implicated in the development of TMEV-induced de-
myelinating disease [3–5], although the relative import-
ance of virus-specific over autoimmune responses to
disease development remains unclear. The majority of
immune responses to TMEV are against the capsid pro-
teins encoded by the P1 region in the TMEV-induced
demyelinating disease [6–8]. We previously showed that
SJL/J mice expressing the TMEV P1 region mounted
lower levels of viral epitope-specific CD4+ and CD8+ T
cell responses throughout the course of viral infection
and developed less severe disease [8]. Lower levels of
virus-specific T cell responses in P1-transgenic SJL/J
mice led to higher viral persistence compared to their
littermates. However, the level of disease development
was also dampened due to the reduced number of
pathogenic T cells in the transgenic mice. In contrast to
the abundant immunological studies on the P1 proteins,
very few studies have investigated the effects of the P2
and P3 regions (non-structural proteins).
We previously demonstrated that the majority CD4+ T
cell responses following TMEV infection in susceptible
SJL mice but not in resistant C57BL/6 mice targeted the
3D polymerase encoded by P3 [9]. This result was con-
sistent with an early study that indicated that transgenic
expression of the TMEV P2/P3 region did not alter the
resistance of C57BL/10 mice (H-2b) to TMEV-induced
disease [10]. However, their subsequent studies with
transgenic mice expressing TMEV 3D in the susceptible
FVB background demonstrated resistance to the patho-
genesis of demyelinating disease [11, 12]. Therefore, it is
conceivable that 3D-transgenic FVB mice may be self-
tolerant to the induction of potentially pathogenic T cell
responses. Investigations into the potential contributions
of P2/P3-specific immune responses to the development
of TMEV-IDD will be valuable for elucidating the poten-
tial roles of the TMEV P2 and P3 regions in the patho-
genesis of demyelinating disease.
To investigate the effects of the P2/P3 genes in the de-
velopment of TMEV-IDD, we generated transgenic mice
expressing the P2 and P3 regions of TMEV under the
control of the hCMV promoter. P2/P3-Tg mice in the
resistant B6 background cleared the viral load similar to
the control B6 mice. In contrast, P2/P3-Tg mice in the
susceptible SJL/J background displayed higher viral loads
in the central nervous system (CNS) but less
pathogenesis. T cell responses to the P1 (structural cap-
sid) and P2/P3 (non-structural protein) epitopes were
significantly reduced in the P2/P3-Tg mice regardless of
their backgrounds. Thus, the reduction in both pro-
tective and pathogenic T cell responses may cause such
increased viral loads but decreased pathogenesis. Inter-
estingly, macrophages and astrocytes from P2/P3-Tg
mice infected with TMEV in vitro produced reduced
levels of IL-6 and viral messages compared to the cells
from naïve control mice. Additionally, NIH-3T3 cells
transfected with P2, P3, or P2/P3 showed marked
inhibition of viral particle production accompanied by an
increase in the type I IFN response compared to untrans-
fected or control plasmid-transfected cells. The inhibition
of viral replication in cells from P2/P3-Tg mice appeared
to be somewhat virus-specific because the replication of
TMEV and closely related encephalomyocarditis virus
(EMCV) was inhibited, whereas the inhibition of the repli-
cation of unrelated vascular stomatitis virus (VSV) was
transient. These results strongly suggest that transgenic
expression of non-structural viral genes may be able to in-
duce innate immunity, which inhibits the initial replica-
tion of related viruses. Thus, these results open the
possibility that gene expression of a part of the viral gen-
ome could be used to prevent the virally induced chronic
disease caused by related viruses.
Methods
Animals
P2/P3-expressing transgenic (B6 X SJL)F1 founders were
generated at the transgenic core facility of Northwestern
University. A transgenic founder F1 mouse was bred
onto the C57BL/6 and SJL/J backgrounds for more than
eight generations in a specific pathogen-free facility prior
to use. The breeder C57BL/6 and SJL mice were pur-
chased from Harlen Laboratories (Indianapolis, IN,
USA). All experiments were conducted with 6- to 10-
week-old females. Experiments using animals were con-
ducted according to the permission (#2011-1316 for
Byung Kim) of the Animal Care and Use Committee at
Northwestern University.
Synthetic peptides and antibodies
All peptides were purchased from GeneMed (GeneMed
Synthesis Inc, South San Francisco, CA, USA) and used
as described previously [13]. All antibodies were pur-
chased from BD Pharmingen (San Diego, CA, USA).
Viruses and cell lines
The BeAn strain of TMEV used in this study was propa-
gated and titered in BHK-21 cells grown in Dulbecco’s
modified Eagle medium supplemented with 7.5 % donor
calf serum. For intracerebral (i.c.) infection, 30 μl of
virus solution containing 3 × 106 PFU was injected into
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the right cerebral hemisphere of 6–8-week-old mice
anesthetized with isoflurane. Clinical symptoms of dis-
ease were assessed weekly using the following grading
scale: grade 0 = no clinical signs; grade 1 =mild waddling
gait or flaccid tail; grade 2 = severe waddling gait; grade
3 =moderate hind limb paresis; and grade 4 = severe
hind limb paralysis.
Reverse-transcription PCR
Total cellular RNA was isolated from various tissues of
P2/3 transgenic mice, including brain, spinal cord, spleen,
thymus, liver, and kidney, using the Trizol® reagent (Invi-
trogen, CA, USA). First-strand complementary DNA
(cDNA) was synthesized from 1 μg of total RNA by utiliz-
ing the SuperScript® III First-Strand Synthesis Supermix
(Invitrogen, CA, USA) at 55 °C. The relative concentra-
tions of cDNA were equalized among the groups based
on the level of glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) amplification (25 cycles) by polymer-
ase chain reaction (PCR). Primers for the control
GAPDH gene and P2/P3 transgene were purchased from
Integrated DNA Technologies: GAPDH, 5′-AACTTTGG
CATTGTGGAAGG-3′ and 5′-ACACATTGGGGGTAG




Virus titers in the infected CNS tissues were enumerated
using a standard plaque assay on BHK-21 cell mono-
layers [14]. To visualize the plaques, the monolayer was
stained using 0.1 % crystal violet after fixation with
methanol.
Isolation of CNS-infiltrating MNC
Mice were perfused with sterile Hank’s balanced salt so-
lution (HBSS), and the excised brains and spinal cords
were homogenized. CNS-infiltrating mononuclear cells
(MNCs) were enriched in the 1/3 bottom fraction of a
continuous 100 % Percoll (Pharmacia, Piscataway, NJ,
USA) gradient after centrifugation for 30 min at
27,000×g, as described previously [15].
Intracellular staining of cytokine production
Freshly isolated CNS-infiltrating MNCs were cultured in
96-well round bottom plates in the presence of relevant
or control peptides as described previously [16].
Allophycocyanin-conjugated anti-CD8 (clone Ly2) or
anti-CD4 (clone L3T4) antibodies and a PE-labeled rat
monoclonal anti-IFN-γ (XMG1.2) antibody were used
for intracellular cytokine staining. Cells were analyzed
on a Becton Dickinson FACS Calibur or FACS Sort flow
cytometer. Live cells were gated based on light scatter
properties.
IFN-γ and IL-17 ELISA
Mouse IFN-γ and IL-17 ELISA kits were purchased from
BD Biosciences (San Diego, CA, USA) and R&D Sys-
tems, Inc. (Minneapolis, MN, USA), respectively. Cyto-
kine levels in splenic culture supernatants were assessed
according to the manufacturer’s instructions. Briefly, di-
luted samples were incubated for 2 h with plate-bound
capture antibodies after blocking for 1 h. Cytokine ex-
pression levels were visualized using HRP-conjugated
detection antibodies in the presence of the HRP sub-
strate TMB (BioFX Laboratories, Owings Mills, MD,
USA). The absorbance was measured at 450 nm.
T cell proliferation assay
The proliferative activity of epitope-specific CD4+ T cells
was measured based on [3H]thymidine incorporation
levels. Spleen cells from P2/P3 transgenic and control
mice 7 dpi were stimulated with PBS, the CD4 peptide
mix, or plate-bound anti-CD3/CD28 antibodies for
3 days, then pulsed with 1 μCi [3H]thymidine-deoxyri-
bose for 18 h. Cells were harvested and 3H incorporation
was measured using TopCount. Data are expressed as
CPM ± SD of triplicates.
Generation of H-2Ks tetramers
H-2Ks tetramers were generated as previously described
[17]. Briefly, H-2Ks and the human β2-microglobulin
gene were subcloned into the pET28 bacterial expression
vector. BL21/DE3 competent cells were transformed and
protein expression was induced with IPTG for 4–5 h. In-
clusion bodies were purified and refolded in the pres-
ence of peptides. The soluble monomeric form of the
peptide-MHC complex was biotinylated with BirA at
room temperature and tetramerized with streptavidin-PE
(Invitrogen, Carlsbad, CA, USA).
Virus replication assay
Plasmids (pMIG) containing the non-structural genes P2,
P3, or P2/P3 were generated after inserting the correspond-
ing genes cloned from pSBW. Phoenix cells were trans-
fected with Lipofectamine-2000 (Invitrogen, Carlsbad, CA,
USA) to generate retroviruses. NIH-3T3 cells were infected
with the recombinant retroviruses at room temperature for
90 min. After 48 h, eGFP-positive cells in the defined gate
were sorted using the FACSAria flow cytometer (BD Biosci-
ences, San Diego, CA, USA). After 2 weeks of rest, the cells
were infected with TMEV at a multiplicity of infection
(MOI) of 10 for 6, 12, 18, and 24 h. Supernatants were col-
lected at each time point for plaque assays. For some exper-
iments, real-time PCR was used to determine gene
expression levels. The lowest expression level was set as
onefold expression.
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Statistical analysis
Data are shown as the mean ± SD of two to three inde-
pendent experiments or triplicates of one representative
experiment from at least three independent experiments.
The significance of differences in the mean values was
determined by Student’s t test. P values < 0.05 were con-
sidered statistically significant.
Results
P2/P3 transgene is expressed in various organs of Tg
mice
To induce “immune unresponsiveness” to the P2/P3 re-
gion gene products, we generated P2/P3 Tg mice with P2/
P3 driven by the human CMV promoter similar to the
previously described P1 Tg mice using the BeAn strain of
TMEV [8]. A transgenic (B6 X SJL)F1 founder expressing
the P2/P3 region of the TMEV genome was bred in the
SJL and B6 backgrounds for at least eight generations
(G8) prior to use (Fig. 1a). To analyze the expression of
the viral P2/P3 genes in the Tg mice, cDNA was prepared
from various organs (brain, spinal cord, spleen, thymus,
and kidney). The 3D polymerase region in the cDNA was
amplified by conventional PCR. Transgene expression was
detectable in all of the organs of the Tg mice but not in
the organs of their littermates (LM) (Fig. 1b). Semi-
quantitative real-time PCR was performed to determine
the relative levels of the transgenes in multiple organs
(Fig. 1c). The levels of Tg expression differed up to 10-fold
among the various organs from Tg mice in the B6 back-
ground, although these expression differences were not
statistically significant. In contrast, Tg mice in the SJL
background showed 10- to 100-fold differences among the
organs. Interestingly, transgene expression was particularly
low in the spinal cords of the SJL Tg mice. However, viral
protein expression in these organs was not detectable by
Western blotting and ELISA using polyclonal antibodies
to the N-terminal peptides of P2 region (not shown).
Therefore, the level of viral proteins produced in the Tg
mice seems to be low.
P2/P3-Tg SJL mice display reduced incidence and severity
of TMEV-induced demyelinating disease compared with
SJL mice
To investigate the impact of P2/P3 expression on virus
persistence and the disease course, we infected P2/P3-Tg
mice and their littermates with TMEV (Fig. 2). During
the 120-day disease course, both the P2/P3-Tg B6 mice
and their littermates remained disease free (data not
shown). However, the P2/P3-Tg SJL mice and their litter-
mates developed clinical signs consistent with the
TMEV-induced demyelinating disease (Fig. 2a). It has
been extensively documented that the TMEV-induced
clinical symptoms faithfully correlate with the cellular
infiltration and demyelination in the white matter,
including TMEV-infected P1-Tg and 3D-Tg mice under
the susceptible backgrounds [8, 12]. Interestingly, the
P2/P3-Tg SJL mice showed reduced disease incidence
and severity compared to their control littermate SJL
mice. We also assessed viral loads in the CNS for correl-
ation with disease development. P2/P3-Tg B6 mice and
their B6 littermates cleared the viral infection by day 21
post-infection (Fig. 2a). In contrast, both the P2/P3-Tg
SJL mice and their littermates failed to clear their viral
loads (Fig. 2b). Interestingly, P2/P3-Tg SJL mice with
higher viral loads in the CNS developed less severe
disease and exhibited a reduced disease incidence
(Fig. 2a, c). These results are consistent with previous
observations [8] indicating that the level of viral per-
sistence is not correlated with the development of
TMEV-IDD and viral persistence itself does not cause
disease development.
Both P1 and P2/P3 epitope-specific CD4+ T cell responses
are reduced in P2/P3-Tg mice compared their control
littermates
It was expected that the P2/P3-Tg mice would induce
comparable T cell responses against the TMEV structural
protein (P1) upon infection, although these Tg mice
might display immune tolerance to the P2/P3 epitopes
due to neonatal exposure to the antigens. To test this
possibility, we analyzed CNS-infiltrating T cells from the
infected mice (Fig. 3). The proportions of both CD4+
and CD8+ T cells were lower in the P2/P3-Tg B6 (Fig. 3a)
and SJL (not shown) mice compared to their control lit-
termates. To examine whether the reduced proportions
of infiltrating T cells reflected a decrease in antigen-
specific T cell responses, we assessed the proportions
and numbers of CNS-infiltrating virus-specific CD4+ T
cells during the course of infection in the P2/P3-Tg and
control mice (Fig. 3b, c). In the P2/P3-Tg B6 mice, the
proportion and number of IFN-γ-producing CD4+ T
cells were much lower at early time points (8 dpi), al-
though they became similar at 21 dpi (Fig. 3b, c). In con-
trast, virus-specific IFN-γ-producing CD4+ T cell
responses to both the non-structural (P = 0.0008) and
structural epitopes (P = 0.00003) in the P2/P3-Tg SJL
mice were severely compromised compared to their
littermates (Fig. 3b, c). These data suggest that the trans-
genic expression of the P2/P3 genes induces a pan-
tolerance of CD4+ T cell responses to TMEV epitopes
rather than tolerance limited to the P2/P3 epitopes.
CD8+ T cell responses to TMEV were significantly reduced
in P2/P3-Tg mice
To examine whether the above pan-tolerance of CD4+ T
cell responses to TMEV in the P2/P3-Tg mice was re-
stricted to CD4+ T cell responses, we assessed CD8+ T
cell responses to viral epitopes (Fig. 4). The proportion
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(P = 0.04) and number (P = 0.016) of IFN-γ-producing
CNS CD8+ T cells in response to the major VP2121-130
capsid epitope at 8 dpi were also significantly lower in
the P2/P3-Tg B6 mice compared with their littermates,
although the T cell responses became similar 21 days
post-infection (Fig. 4a, b). The reduction in IFN-γ-
producing TMEV capsid-specific CD8+ T cell responses
in the P2/P3-Tg SJL mice was even more prominent
and was sustained throughout the course of viral
infection (Fig. 4a, b). The differences between the P2/
P3-Tg SJL and control mice were significant [VP3159–
166-specific CD8
+ T cells (P = 0.002), VP3173–181-specific
CD8+ T cells (P = 0.004), and VP111–20-specific CD8
+ T
cells (P = 0.0009)]. Although IFN-γ production in re-
sponse to CD8 epitopes was low, it was possible that
the infected P2/P3-Tg mice mounted a comparable
level of virus-reactive CD8+ T cells that did not pro-
duce IFN-γ. To test this possibility, we assessed the
Fig. 1 Expression of viral P2/P3 transgenes in multiple organs. a Schematic diagram of the P2/P3 construct controlled by the CMV promoter. BGH
pA represents the bovine growth hormone polyadenylation signal. (C57BL/6 X SJL)F1 founder mice were backcrossed to either B6 or SJL mice
more than eight times. b The expression of the 3D transgene region in the brain (Br), spinal cord (SC), spleen (Spl), thymus (Thy), liver (Liv), and
kidney (Kid) was examined by RT-PCR. Littermates (LM) negative for the transgene resulting from the backcrossing were used as the control mice.
Amplification of the GAPDH gene was compared with the viral gene expression in the samples. Representative RT-PCRs of Tg lines in the C57BL/
6 and SJL backgrounds are shown. c Relative levels of transgene expression in various organs were compared using semi-quantitative real-time
PCR. DNase pre-treated total RNA was used to synthesize the cDNA. The statistical significance of the differences was analyzed by Student’s t test.
*P < 0.05; **P < 0.01
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binding ability of CD8+ T cells to epitope-loaded MHC
class I tetramers (Fig. 4c). Interestingly, VP2121–130-
loaded H-2Db molecules stained a comparable portion
of CNS-infiltrating CD8+ T cells 8 dpi in the infected
P2/P3-Tg B6 mice (Fig. 4c left). In contrast, the propor-
tions of CD8+ T cells in the P2/P3-Tg SJL mice that
bound to H-2Ks tetramers containing the VP3159–166 and
VP3173–181 epitopes were significantly lower compared to
the control SJL mice (Fig. 4c right), which is similar to the
proportions of IFN-γ producing CD8+ T cells (Fig. 4a, b).
These results suggest that the quality and quantity of virus-
specific CD8+ T cells are more severely altered in P2/P3-Tg
mice in the susceptible SJL background compared to P2/
P3-Tg mice in the resistant B6 background.
P2/P3-Tg mice display T cell unresponsiveness to viral
epitopes in the periphery
Although T cell responses to viral epitopes in the CNS of
infected P2/P3-Tg mice were significantly reduced (Figs. 3
and 4), it was unclear whether the reduced T cell responses
were limited to the CNS or represented generalized T cell
unresponsiveness to the virus. To address this issue, we an-
alyzed virus-specific T cell responses in the spleen by meas-
uring IFN-γ levels after stimulation with the indicated
epitope peptides (Fig. 5a). Splenic T cells from infected P2/
P3-Tg B6 mice produced drastically reduced levels of IFN-γ
upon stimulation with P1-encoded capsid epitopes (S mix)
compared to infected B6 mice. IFN-γ production in re-
sponse to the P2/P3-encoded non-structural epitopes (NS
mix) in the control mice was minimal. In contrast, IFN-γ
levels produced by splenic T cells from P2/P3-Tg SJL mice
in response to both the S mix and NS mix were signifi-
cantly reduced compared to the control SJL mice. To con-
firm this virus-specific unresponsiveness, the proliferative
response and IFN-γ production in response to viral epi-
topes versus general T cell stimulation (anti-CD3 and anti-
CD28) were measured (Fig. 5b). The proliferative response
of splenic T cells from P2/P3-Tg mice to viral epitope (CD4
mix) stimulation but not to pan T cell stimulation was sig-
nificantly reduced compared to the control mice. Similarly,
IFN-γ production by splenic T cells from the Tg mice in re-
sponse to viral epitopes but not to pan T cell stimulation
(anti-CD3/anti-CD28 antibodies) was also diminished.
These results strongly suggest that P2/P3-Tg expression in
mice induces T cell unresponsiveness to the entire viral epi-
topes including the transgene products but not to unrelated
T cell responses.
We further tested the capacity of splenic CD11C+ den-
dritic cells and peritoneal macrophages from the P2/P3
Tg mice against purified splenic CD4+ T cells from
Fig. 2 Reduced disease severity but elevated viral loads in TMEV-infected P2/P3-Tg mice in the SJL background. a Development of clinical disease
in TMEV-infected P2/3-Tg mice (n = 15) and their littermates (LM, n = 15) in the SJL background was examined for 120 days after infection with
TMEV. Clinical symptoms were assessed weekly based on behavioral changes as described in the “Methods” section. No clinical symptoms were
developed in the P2/P3-Tg mice in the B6 background (data not shown). b The titers of the infectious virus in the CNS of TMEV-infected P2/P3-Tg mice
and their littermates were determined by plaque assay on the indicated number of days post-infection. The PFU numbers represent the PFUs per
whole brain or spinal cord calculated from the pool of three to four mice per group. The statistical significance of the differences was analyzed by
Student’s t test between control and Tg mice. *P < 0.05; **P < 0.01; and ***P < 0.001. d8, d21, and d120 represent day 8, day 21, and day 120
post-infection, respectively
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TMEV-infected non-Tg mice (not shown). There were
no differences in the efficiencies in the T cell stimulation
between the antigen-presenting cells from the control
vs. P2/P3-Tg mice. In addition, T cell responses of the
P2/P3-Tg mice to unrelated ovalbumin antigen following
ovalbumin immunization were not different from those
of the control mice similarly immunized with ovalbumin
(not shown). These results strongly suggested that the
above reduction in the T cell responses is specific against
viral determinants (Fig. 5) and no deficiencies in the T
cell responses to unrelated antigens. In addition, the
viability of T cells or antigen-presenting cells between
control and the P2/P3-Tg mice was not different.
Viral replication in vitro is compromised in various cell
types from P2/P3-Tg mice
To elucidate the underlying mechanism of the reduced T
cell responses in the P2/P3-Tg mice, we compared the
levels of IL-6 (a representative innate pro-inflammatory
cytokine) and viral replication between cells from P2/P3-
Tg mice and the control mice. We tested two important
cell types supporting viral persistence in the brain
Fig. 3 Levels of antigen-specific IFN-γ-producing CD4+ T cells in the CNS of TMEV-infected P2/P3-Tg mice (Tg) and their littermates (LM). a Splenocytes
and CNS-infiltrating MNCs isolated from TMEV-infected mice were stained with CD4 and CD8. b CNS-infiltrating MNCs were restimulated with the mixture
of CD4+ T cell-specific epitopes (mix for cells from B6 mice, VP2206–220, and VP425–38; S mix for cells from SJL mice, VP1233–250, VP274–86, and VP324–37; NS
mix, 3D6–23, and 3D20–38). After 6 h of stimulation, the cells were stained for CD4 and intracellular IFN-γ. The percentages of CD4+ and IFN-γ+ cells are
shown in the upper left corner. Data are representative of three independent experiments. c Histograms represent the mean percentages (upper panels)
and the numbers (lower panels) from three independent experiments assessed by flow cytometric analysis. Statistical significance was analyzed by Student’s
t test. *P< 0.05; **P< 0.01; and ***P< 0.001
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(macrophages and astrocytes) after 18 h of infection with
TMEV in vitro. Both IL-6 production and virus replication
were lower in the cells from the Tg mice (Fig. 6a, b), sug-
gesting that the levels of viral replication and the associ-
ated pathogenic innate cytokines were compromised in
cells expressing the P2/P3 transgenes.
Because the overall T cell responses toward TMEV were
lower in the Tg mice compared to the WT mice (Figs. 3, 4,
and 5), we compared the antigen-presenting function of
virus-infected cells (Fig. 6c). To compare antigen presenta-
tion by virus-infected cells, we utilized CD11c+ cells and/
or peritoneal macrophages isolated from the WT and Tg
mice as APCs to stimulate virus-specific T cell
proliferation. CD4+ T cells isolated from the spleens of
TMEV-infected mice were co-cultured with the APCs in
the presence of the CD4 peptide mix (already processed
form), UV-TMEV (unprocessed form), and live TMEV
(self-replicative form) for 72 h. Virus-specific T cell prolif-
eration levels induced by the APCs did not differ between
the APCs from the Tg and control mice (Fig. 6c), suggest-
ing that the antigen-presenting function of APCs of the Tg
mice was not affected.
Replication of related viruses is inhibited in P2/P3-Tg mice
We compared the replication of other viruses, including
the closely related encephalomyocarditis virus (EMCV)
Fig. 4 Antigen-specific IFN-γ-producing CD8+ T cell levels in the CNS of TMEV-infected P2/P3-Tg mice. a CNS-infiltrating cells from P2/P3-Tg mice
and their littermates were isolated at 8, 21, and 120 days pi and stimulated with the indicated peptides (2 μM) for 6 h. Then, the cells were
stained for both CD8 and intracellular IFN-γ, followed by flow cytometric analysis. The percentage of IFN-γ+ and CD8+ T cells is shown in the
upper left quadrant of each plot. A representative flow cytometry plot from three independent experiments is shown. d8, d21, and d120 represent
day 8, day 21, and day 120 post-TMEV infection, respectively. Tg and LM indicate P2/P3-Tg and littermate mice, respectively. b The proportions
and the total numbers of epitope-specific IFN-γ-producing CD8+ T cells (left for B6 and right for SJL mice) are presented. c The proportions of
Db-VP2121–130 tetramer-staining CD8
+ T cells in the CNS of B6 mice and the proportions of Ks-VP3-159–166 and VP3-173–181 tetramer-positive CD8
+ T
cells in the CNS of SJL mice at 8 dpi are shown. Values given represent the mean percentages or numbers (±SD) of the results from three independent
experiments. *P < 0.05; **P < 0.01; and ***P < 0.001
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and vascular stomatitis virus (VSV), in the P2/P3-Tg and
control mice. We tested viral RNA levels 1 and 2 days
after virus infection (Fig. 7). The mice died within 3 days
of intracerebral infection of both VSV and EMCV due to
severe viremia and wasting disease. Replication of both
TMEV and the closely related EMCV were significantly
reduced at both time points. However, the replication of
unrelated VSV was transiently reduced (reduction was
observed at day 1 but not day 2 post-infection). These
results suggest that mice expressing the TMEV P2/P3
transgene display efficient inhibition of the replication of
related viruses.
In vitro expression of the P2 and P3 genes in NIH-3T3
cells inhibits viral replication
Because the P2/P3-Tg mice express both the TMEV P2
and P3 genes, it is unclear whether P2 or P3 is respon-
sible for these inhibitory effects. Additionally, whether
gene expression in a cell line can duplicate the inhibition
of viral replication remains unknown. To assess these
possibilities, we infected mouse NIH-3T3 cells with ret-
roviruses carrying a GFP-containing vector (pMIG)
alone or pMIG containing the P2, P3, or P2/P3 genes
and sorted cells displaying similar GFP intensities
(Fig. 8a). Viral loads were measured in these cells 6, 12,
18, and 24 h post-TMEV infection (Fig. 8b). Interest-
ingly, 3T3 cells carrying P2, P3, or P2/P3 showed
Fig. 5 Effect of P2/P3 transgenes on the expression of cytokines in
infected mice. a IFN-γ levels in the supernatants of the splenic
cultures were determined by ELISA. Spleen cells were prepared
8 days post-infection from B6 and SJL mice (n = 3). Cells were
cultured for 72 h in the presence of PBS or a mixture of 1 μM
peptides. Culture supernatants were collected for ELISA. S mix for
cells from B6 mice, VP2206–220, and VP425–38; S mix for cells from SJL
mice, VP1233–250, VP274–86, and VP324–37; and NS mix for both, 3D6–23
and 3D20–38. b The proliferative response of epitope-specific CD4
+ T
cells was measured based on [3H]-thymidine incorporation levels.
Spleen cells from wild-type or P2/P3 transgenic B6 mice were
stimulated with PBS, the CD4 peptide mix (VP2206–220 and VP425–38) or
plate-bound anti-CD3/CD28 antibodies. IFN-γ levels in the supernatants
of the cultures were assessed with ELISA. Values given are the means
(±SD) of the results from triplicate wells. *P < 0.05; and ***P < 0.001
Fig. 6 Expression of viral and IL-6 genes in different cell types. a IL-6
expression and virus replication were tested in peritoneal macrophages
from P2/P3-B6 mice. Peritoneal macrophages were infected with 1 or 5
MOI of TMEV for 18 h. The level of TMEV-VP1 reflecting viral replication
was compared by real-time PCR. b IL-6 expression and virus replication
in astrocytes were also tested after infection with TMEV (MOI of 2
and 10) for 18 h. (c) Antigen-presenting function of cells from control
and Tg mice was tested based on the induction of T cell proliferation.
Peritoneal macrophages or splenic CD11C+ DC cells were prepared
from WT and P2/P3 Tg B6 mice. Positively purified splenic CD4+ cells
from TMEV-infected B6 mice were cultured with macrophages or DCs
as APCs for 48 h in the presence of PBS, CD4 peptides, UV-TMEV, or
infectious TMEV, followed by 18 h of incubation with 1 μCu 3H-TdR.
Values given are the means (±SD) of the results from triplicate
cultures. *P < 0.05
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significantly reduced replication, with the most signifi-
cant reduction observed in the P2-carrying cells. Viral
RNA production levels in these cells (Fig. 8c) were con-
sistent with the virion production measured by plaque
assay (Fig. 8b). Interestingly, IFN-α and IFN-β levels in
3T3 cells carrying the P2 or P3 genes were significantly
higher than either the uninfected or control (vector)
retrovirus-infected cells (Fig. 8c). These results strongly
suggest that the expression of the TMEV P2 or P3 gene
induces elevated type I IFNs upon viral infection.
Fig. 7 Effects of P2/P3 transgene expression on the replication of other viruses. Replication levels of TMEV, related EMCV, and unrelated VSV were
tested after intracerebral infection of the viruses into control and Tg mice. Viral replication levels in the brains of infected mice 1 and 2 days post-
infection were assessed using real-time PCR. Levels of viral genes were compared after normalization with GAPDH. Values given are the means
(±SD) of the results from triplicate wells. *P < 0.05; **P < 0.01
Fig. 8 Decreased viral replication in NIH-3T3 cells transfected with the P2 and/or P3 genes. a Selection of NIH-3T3 cell lines expressing the P2, P3,
and P2/P3 genes. Retroviruses containing the P2, P3, and P2/P3 genes were produced in Phoenix cells using the pMIG retroviral vector. NIH-3T3
cells were infected with the recombinant retroviruses. After a 2-week rest period, GFP-positive cells with MFI intensity between 3000 and 7500
were sorted with Moflo. Uninfected 3T3 cells (clear histogram) were compared with 3T3 cells infected with retroviruses containing the viral genes
(shaded histogram). b Infectious virus levels produced 48 h post-infection with TMEV (MOI = 10) were compared by standard plaque assay using
BHK-21. pMIG and 3T3 cells infected with retrovirus containing empty vector; P2, pMIG-P2; P3, pMIG-P3; P2/P3, pMIG-P2/P3; and 3T3, untransfected
NIH-3T3 cells. c Expression of viral, IFN-α, and IFN-β messages was assessed by real-time PCR at 6, 12, 18, and 24 h post-infection. Values given are the
means (±SD) of the results from triplicate wells. *P < 0.05; **P < 0.01
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Consequently, viral replication in cells expressing these
genes is most likely inhibited via the down stream IFN-
stimulating genes.
Discussion
The expression of transgenes in mice has been utilized
as an important tool to investigate various immune
mechanisms, such as unresponsiveness, autoimmunity,
and T cell development [18–20]. We previously demon-
strated that transgenic mice carrying the TMEV P1 gene
encoding a viral structural protein displayed reduced
virus-specific immune responses, resulting in reduced
pathogenesis in the transgenic mice despite the in-
creased viral loads in the CNS [8]. Therefore, viral per-
sistence does not always lead to TMEV-IDD, although
viral persistence has long been believed to have a major
impact on the development of TMEV-IDD [21].
In the present study, we established P2/P3-Tg mice to
dissect the role of non-structural proteins in the devel-
opment of TMEV-induced demyelinating disease. We
demonstrated that P2/P3-Tg mice (particularly in the
susceptible SJL background) displayed elevated viral per-
sistence in the brain and later in the spinal cord (Fig. 2).
However, P2/P3-Tg mice developed significantly less se-
vere and less frequent disease (Fig. 2). These data sug-
gest that viral persistence may not directly correlate with
disease development. This finding is consistent with our
previous data demonstrating that P1-Tg SJL/J mice with
higher viral loads at all stages of viral infection com-
pared to their littermates developed less severe disease
[8]. The lack of correlation between viral persistence and
disease development implies that viral persistence alone
may not be able to drive the development of TMEV-
IDD. Indeed, TMEV-infected P2/P3-Tg mice mounted
lower levels of anti-TMEV T cell responses (Figs. 3, 4,
and 5). The lower levels of protective antiviral T cell re-
sponses in the P2/P3-Tg mice under persistent inflam-
matory environment may have contributed to the
elevated viral persistence in the CNS.
The P2/P3-Tg mice were expected to mount un-
affected immune responses specific to the epitopes
encoded by the P1 genes. However, the P2/P3-Tg SJL
mice exhibited severely compromised virus-specific T
cell responses to the structural epitopes encoded by the
P1 region (Fig. 3b, c). The presence of excessive levels of
type I IFNs is known to exert severe suppression of
adaptive immune responses in SJL mice via the inhib-
ition of development and function of antigen-presenting
cells [22]. Therefore, the excessive production of type I
IFNs in the cells expressing P2 and/or P3 genes, as well
as P2/P3-Tg SJL mice (Figs. 6 and 8) most likely results
in the compromised adaptive immune responses to viral
antigens, which are responsible for the pathogenesis and
the protection. Furthermore, the cells expressing the P2
and/or P3 genes produce lower levels of IL-6 upon
TMEV infection (Fig. 6), which may curtail the gener-
ation of pathogenic T cells [23, 24]. Collectively, the
lower initial viral replication leading to the low level of
anti-viral T cell responses in P2/P3-Tg mice combined
with the low level of pathogenic T cell responses may re-
sult in elevated viral persistence in the absence of the
pathogenesis of demyelinating disease. In contrast to the
viral persistence in the infected P2/P3-Tg SJL mice
(Fig. 2), cells expressing the P2 and/or P3 genes from
the P2/P3-Tg mice or cells transfected with P2 or P3
displayed reduced TMEV replication in vitro (Figs. 6
and 8). Because the viral replication experiments in
vitro do not involve adaptive anti-viral immunity, the
viral replication level in vitro does not correspond to
viral persistence in the infected mice where strong
adaptive immune responses are necessary to control
viral persistence. Therefore, the protective type I IFNs
that are elevated in the P2/P3-expressing cells may be
sufficient to hinder viral replication in vitro.
Interestingly, the inhibition of viral replication is par-
tially preferential for the same family of viruses because
TMEV and EMCV, which belong to the same cardiovirus
genus of the picornavirus family, are selectively inhibited
compared to VSV, which is not a member of picornaviri-
dae (Fig. 7). The underlying mechanism of viral replica-
tion inhibition is not clear. The elevated production of
type I IFNs upon viral infection in cells from P2/P3-Tg
mice (Fig. 8) suggests that these cytokine levels may
affect viral replication. Recently, the expression of
TMEV 3D in susceptible FVB mice showed an antiviral
effect through elevated type I interferon expression [12].
Although the immune responses were not assessed in
the TMEV DA strain 3D-Tg FVB mice, they concluded
that adaptive immune responses are not an important
contributing factor because 3D-expressing Rag-deficient
FVB mice, which lack immune responses, provided pro-
tection. However, our results obtained with P2/P3-Tg
mice (Figs. 3, 4, and 5) indicate that virus-specific adap-
tive immune responses also contribute to the pathogen-
esis of TMEV-induced demyelinating disease. Our
attempts to individually express the 2A, 2B, 2C, 3A, 3C,
and 3D genes to assess their inhibitory functions in the
mouse cell line were not successful, suggesting that
uncleaved non-structural proteins or contiguous viral
genome sequences may be important for the inhibitory
function (data not shown).
The protein encoded by the 3A gene in the P3 of
poliovirus inhibits protein secretion by blocking endo-
plasmic reticulum-to-Golgi transport [25, 26]. This in-
hibition of protein secretion may play a role in the
immune-evading mechanism of poliovirus through the
down-regulation of MHC class I-dependent viral antigen
presentation [27] and the reduction of innate cytokine
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secretion [28]. However, the inhibitory ability of the
TMEV 3A protein was absent [29]. Interestingly, the
uncleaved 2BC protein encoded by the P2 genes (rather
than 3A) of foot-and-mouth disease virus (FMDV) ex-
hibited a similar inhibitory function [30]. Therefore, 2BC
of TMEV, which is similar to FMDV with respect to its
resistance to bredfeldin A [30], may play an important
role in immune evasion by dampening virus-specific T
cell responses. In addition to P2, the expression of the
P3 and P2/P3 genes also inhibited viral replication over
twofold compared to the controls (Figs. 6 and 8). There-
fore, a protein encoded by the genes or a viral genome
segment of P3 appears to inhibit viral replication inde-
pendently of P2. It is conceivable that the 3D region of
TMEV in the P3 segment may inhibit viral replication
as previously reported [12]. A very recent study using
the TMEV DA 3D-Tg model has suggested that the
catalytic site of 3D protein is associated with elevated
production of type I IFNs [31]. Interestingly, cells ex-
pressing the P2 or P3 genes displayed elevated produc-
tion of type I IFNs upon viral infection (Fig. 8). This
result is consistent with the previous observation with
3D-Tg mice. However, our results with TMEV BeAn
P2/P3-Tg mice suggest that the P2 region, in addition
to the P3 (including 3D) is also capable of inducing the
production of type I IFNs. Although we failed to detect
any measurable levels of viral proteins encoded by the
P2 and P3 genes based on the polyclonal rabbit antibodies
to the primary amino acid sequences of the N-termini of
2A, 2B, and 3D, the potential involvement of the unfolded
protein response (UPR) to the P2/P3 products, which is
capable of inducing type I IFNs [32, 33], cannot be ex-
cluded. Nevertheless, distinct mechanisms must be oper-
ational between the P2 and P3 gene products in the
induction of innate immune responses.
The underlying mechanism responsible for the elevated
type I IFN production in cells expressing the P2 and/or P3
genes is not clear. It is conceivable that some host pattern-
recognizing molecules (e.g., TLRs such as TLR7/8 and
TLR9) recognize either the viral proteins or nucleic acids
encoded by the P2/P3 region and consequently trigger in-
nate cytokine production [34]. We previously showed that
TMEV infection triggers TLR-mediated innate cytokine
production in mice via interaction with viral double-
stranded RNA (dsRNA) replication intermediates [35–37].
In addition, we demonstrated that TMEV infection trig-
gers innate immunity in the host via melanoma
differentiation-associated 5 (MDA-5) protein [38], which
involves a group of intracellular responders, the retinoic
acid-inducible gene I-like receptors (RLR) [39]. Signaling
pathways of dsRNAs, non-self RNAs, and certain DNAs
share the involvement of IPS-1/MAVS, which is associated
with RLR-mediated signaling [40–42]. The protection
against viral infection in the TMEV 3D-Tg model, which is
dependent on the presence of MDA-5 or MAVS signaling
[31], supports this possibility. Because viral DNA is
transcribed in transgenic cells to produce viral RNAs
encoding the P2 and P3 regions (Fig. 2), structural
features of viral RNA branches in the P2 and P3
region of TMEV may be recognized by MDA-5 as
previously proposed [43–45]. This possibility is sup-
ported by the fact that similar inhibition of viral rep-
lication is observed in cells containing the P2 and/or
P3 regions as the RNA form after infection with the
recombinant retroviruses (Fig. 8). This possibility is
also consistent with the results indicating that cells
expressing TMEV genes inhibit not only TMEV repli-
cation but also replication of closely related EMCV
compared to that of unrelated VSV (Fig. 7). Neverthe-
less, viral DNA and/or RNA transcripts from the viral
transgenes may trigger innate cytokine production via
TLR-dependent and/or independent pathways [34,
46–48]. Further studies on the mechanism underlying
the non-structural gene-mediated antiviral effect
might lead to the development of powerful new anti-
viral drugs or treatments.
Conclusions
We demonstrated here that transgenic SJL mice express-
ing the non-structural genes (P2 and/or P3) of TMEV
showed severely suppressed anti-viral immune responses
to broad viral determinants, including the epitopes
encoded by the P1 structural genes. These P2/P3-Tg SJL
mice were resistant to the TMEV-induced demyelinating
disease despite their elevated viral loads in the CNS
throughout the viral infection. However, the early viral
loads (2–3 days) in the CNS of the P2/P3-Tg mice were
low after infection with TMEV and closely related
EMCV compared to unrelated VSV. Further experiments
indicated that the production of type I IFNs in cells ex-
pressing the P2 and/or P3 RNAs was markedly elevated
upon viral infection but the production of IL-6 was
inhibited. Based on these results, we hypothesize that
excessive production of type I IFNs in the Tg mice ex-
pressing the non-structural viral genes suppresses the in-
duction of pathogenic as well as protective adaptive
immune responses, resulting in the resistance to the de-
myelinating disease yet increased viral loads in the CNS.
The fact that more efficient inhibition against a related
virus compared to an unrelated virus strongly suggests a
role of innate immunity induced by the P2 and P3
RNAs, which recognizes the similarity in the viral gen-
ome structures such as MDA-5. Alternatively, VSV may
be able to respond to the innate immune responses dif-
ferently from the related picornavirus family members.
Nevertheless, the expression of viral non-structural
genes may serve as a useful new method to prevent a
broadly virus-specific pathogenesis in the hosts.
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